DaVita
DVA
$93.67
Share price
1.35%
Change (1 day)
-3.92%
Change (1 year)
Categories
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.
Revenue for DaVita (DVA)
Revenue in 2023 (TTM): $11.66 B
According to DaVita's latest financial reports the company's current revenue (TTM) is $11.66 B. In 2022 the company made a revenue of $11.60 B a decrease over the years 2021 revenue that were of $11.61 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for DaVita from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $11.66 B | 0.47% |
| 2022 | $11.60 B | -0.08% |
| 2021 | $11.61 B | 0.59% |
| 2020 | $11.55 B | 1.42% |
| 2019 | $11.38 B | -0.14% |
| 2018 | $11.40 B | -20.13% |
| 2017 | $14.27 B | -3.16% |
| 2016 | $14.74 B | 6.99% |
| 2015 | $13.78 B | 7.71% |
| 2014 | $12.79 B | 8.76% |
| 2013 | $11.76 B | 42.82% |
| 2012 | $8.23 B | 17.88% |
| 2011 | $6.98 B | 8.38% |
| 2010 | $6.44 B | 5.54% |
| 2009 | $6.10 B | 7.93% |
| 2008 | $5.66 B | 7.52% |
| 2007 | $5.26 B | 7.86% |
| 2006 | $4.88 B | 64.12% |
| 2005 | $2.97 B | 29.38% |
| 2004 | $2.29 B | 12.32% |
| 2003 | $2.04 B | 10.34% |
| 2002 | $1.85 B | 12.35% |
| 2001 | $1.65 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Universal Health Services
UHS | $13.57 B | 16.36% | 🇺🇸 USA |
 LabCorp LH | $14.75 B | 26.49% | 🇺🇸 USA |
 Tenet Healthcare THC | $19.45 B | 66.74% | 🇺🇸 USA |
 Pediatrix Medical Group MD | $1.98 B | -83.02% | 🇺🇸 USA |